Modified Danggui Beimu Kushen Pills Inhibit Tumor Growth and Regulates T Cell Subsets in H22 Hepatocellular Carcinoma-bearing Mice
|更新时间:2024-06-18
|
Modified Danggui Beimu Kushen Pills Inhibit Tumor Growth and Regulates T Cell Subsets in H22 Hepatocellular Carcinoma-bearing Mice
“The latest research has found that the modified Danggui Beimu Kushen Wan can significantly inhibit tumor growth in H22 liver cancer mice and provide experimental evidence for the combined treatment of liver cancer with immune checkpoint antibodies by regulating T cell immune activity.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 12, Pages: 87-96(2024)
MA Xiaojie,LIU Ben,WANG Lei,et al.Modified Danggui Beimu Kushen Pills Inhibit Tumor Growth and Regulates T Cell Subsets in H22 Hepatocellular Carcinoma-bearing Mice[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(12):87-96.
MA Xiaojie,LIU Ben,WANG Lei,et al.Modified Danggui Beimu Kushen Pills Inhibit Tumor Growth and Regulates T Cell Subsets in H22 Hepatocellular Carcinoma-bearing Mice[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(12):87-96. DOI: 10.13422/j.cnki.syfjx.20232224.
Modified Danggui Beimu Kushen Pills Inhibit Tumor Growth and Regulates T Cell Subsets in H22 Hepatocellular Carcinoma-bearing Mice